Access to quality vaccines, medicines, and health technologies in Rwanda
KWIGIRA
>
Rwanda show map
Access to quality vaccines, medicines, and health technologies in Rwanda
Global Gateway: MSc and PhD programmes in Biotechnology launched in partnership between Team Europe and University of Rwanda
EU-Enabel contribution to Rwanda’s Health workforce through Master and PhD programmes in Biotechnology
Preparedness workshop to implement MSc Programme in Biotechnology
| Résumé projet | |
|
Strengthen entrepreneurship and to improve the business environment and attractiveness of investment in Rwanda, including pharmaceutical investments. |
|
| Code | RWA21001 |
| Date de début | 18 April 2022 |
| Date de fin | 18 April 2026 |
| Phase | Execution |
| Bailleur | European Union |
| Secteur | 25010 Business support services and institutions |
| Budget | 7 042 056.00 € |
Objectif général
The business environment and attractiveness of Rwanda for pharmaceutical investments is enhanced to ensure access to quality vaccines, medicines, and health technologies in Africa
Objectifs spécifiques
A - To assist Rwanda FDA to adequately perform its mission to protect public health and to reach and maintain maturity level 3 of WHO Global Benchmarking Tool (GBT) to fully regulate pharmaceutical products including vaccines manufacturing in Rwanda.
Actualités
Pas d'actualité